KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Date Action Amount Person Type
Aug 12, 2022 Sell 8 994 Giordano Michael F Common Stock, par value $0.0001
Aug 12, 2022 Sell 13 060 Goldfischer Carl Common Stock, par value $0.0001
Aug 12, 2022 Sell 8 994 Goldfischer Carl Common Stock, par value $0.0001
Aug 12, 2022 Sell 3 380 951 Goldfischer Carl Common Stock, par value $0.0001
Aug 12, 2022 Sell 53 324 Conroy Kevin T Common Stock, par value $0.0001
Aug 12, 2022 Sell 8 994 Richon Victoria Common Stock, par value $0.0001
Aug 12, 2022 Sell 215 494 Mott David M Common Stock, par value $0.0001
Aug 12, 2022 Sell 215 494 Mott David M Common Stock, par value $0.0001
Aug 12, 2022 Sell 106 959 Mott David M Common Stock, par value $0.0001
Aug 12, 2022 Sell 8 994 Mott David M Common Stock, par value $0.0001
Aug 12, 2022 Sell 20 341 Beveridge, Roy A Common Stock, par value $0.0001
Aug 12, 2022 Sell 25 696 Beveridge, Roy A Common Stock, par value $0.0001
Aug 12, 2022 Sell 179 247 Agarwal Shefali Common Stock, par value $0.0001
Aug 12, 2022 Sell 107 292 Agarwal Shefali Common Stock, par value $0.0001
Aug 12, 2022 Buy 0 Korn Jerald
Aug 12, 2022 Sell 8 994 Royalty Pharma Investments 2019 Icav Restricted Stock Units
Aug 12, 2022 Sell 31 933 334 Royalty Pharma Investments 2019 Icav Common Stock, par value $0.0001
Aug 12, 2022 Sell 30 181 Beaulieu Joseph Common Stock, par value $0.0001
Aug 12, 2022 Sell 30 181 Beaulieu Joseph Common Stock, par value $0.0001
Aug 12, 2022 Sell 21 895 Beaulieu Joseph Common Stock, par value $0.0001
Aug 12, 2022 Sell 8 060 Bate Kenneth Common Stock, par value $0.0001
Aug 12, 2022 Sell 8 060 Bate Kenneth Common Stock, par value $0.0001
Aug 12, 2022 Sell 8 994 Bate Kenneth Common Stock, par value $0.0001
Aug 12, 2022 Sell 39 046 Kutok Jeffery Common Stock, par value $0.0001
Aug 12, 2022 Sell 81 021 Kutok Jeffery Common Stock, par value $0.0001
Aug 12, 2022 Sell 25 696 Stuckley Carol Common Stock, par value $0.0001
Aug 12, 2022 Sell 84 170 Bogle Grant C. Common Stock, par value $0.0001
Aug 12, 2022 Sell 84 170 Bogle Grant C. Common Stock, par value $0.0001
Aug 12, 2022 Sell 175 000 Bogle Grant C. Common Stock, par value $0.0001
Aug 09, 2022 Buy 800 000 Bogle Grant C. Common Stock, par value $0.0001
Aug 09, 2022 Buy 417 500 Bogle Grant C. Common Stock, par value $0.0001
Aug 09, 2022 Sell 395 083 Bogle Grant C. Common Stock, par value $0.0001
Aug 09, 2022 Sell 746 307 Bogle Grant C. Common Stock, par value $0.0001
Aug 09, 2022 Sell 417 500 Bogle Grant C. Stock Option (Right to Buy)
Aug 09, 2022 Sell 800 000 Bogle Grant C. Stock Option (Right to Buy)
Aug 09, 2022 Sell 417 500 Bogle Grant C. Stock Option (Right to Buy)
Aug 09, 2022 Buy 400 000 Agarwal Shefali Common Stock, par value $0.0001
Aug 09, 2022 Sell 56 527 Agarwal Shefali Stock Option (Right to Buy)
Aug 09, 2022 Sell 43 473 Agarwal Shefali Stock Option (Right to Buy)
Aug 09, 2022 Sell 373 154 Agarwal Shefali Common Stock, par value $0.0001
Aug 09, 2022 Buy 43 473 Agarwal Shefali Common Stock, par value $0.0001
Aug 09, 2022 Buy 56 527 Agarwal Shefali Common Stock, par value $0.0001
Aug 09, 2022 Sell 400 000 Agarwal Shefali Stock Option (Right to Buy)
Aug 09, 2022 Sell 400 000 Agarwal Shefali Stock Option (Right to Buy)
Aug 09, 2022 Buy 300 000 Beaulieu Joseph Common Stock, par value $0.0001
Aug 09, 2022 Sell 279 864 Beaulieu Joseph Common Stock, par value $0.0001
Aug 09, 2022 Sell 300 000 Beaulieu Joseph Stock Option (Right to Buy)
Aug 09, 2022 Sell 300 000 Beaulieu Joseph Stock Option (Right to Buy)
Aug 09, 2022 Buy 380 000 Kutok Jeffery Common Stock, par value $0.0001
Aug 09, 2022 Sell 354 496 Kutok Jeffery Common Stock, par value $0.0001
Aug 09, 2022 Sell 380 000 Kutok Jeffery Stock Option (Right to Buy)
Jun 30, 2022 Buy 16 156 Mott David M Common Stock, par value $0.0001
Jun 30, 2022 Buy 8 928 Beveridge, Roy A Common Stock, par value $0.0001
Jun 30, 2022 Buy 10 204 Conroy Kevin T Common Stock, par value $0.0001
May 17, 2022 Buy 41 006 Royalty Pharma Investments 2019 Icav Stock Option (Right to Buy)
May 17, 2022 Buy 41 006 Bate Kenneth Stock Option (Right to Buy)
May 17, 2022 Buy 41 006 Bate Kenneth Stock Option (Right to Buy)
May 17, 2022 Buy 8 994 Bate Kenneth Common Stock, par value $0.0001
May 17, 2022 Buy 8 994 Richon Victoria Common Stock, par value $0.0001
May 17, 2022 Buy 8 994 Stuckley Carol Common Stock, par value $0.0001
May 17, 2022 Buy 41 006 Giordano Michael F Stock Option (Right to Buy)
May 17, 2022 Buy 8 994 Mott David M Common Stock, par value $0.0001
May 17, 2022 Buy 41 006 Mott David M Stock Option (Right to Buy)
May 17, 2022 Buy 8 994 Conroy Kevin T Common Stock, par value $0.0001
May 17, 2022 Buy 41 006 Goldfischer Carl Stock Option (Right to Buy)
May 17, 2022 Buy 8 994 Goldfischer Carl Common Stock, par value $0.0001
May 17, 2022 Buy 41 006 Beveridge, Roy A Stock Option (Right to Buy)
May 17, 2022 Buy 8 994 Beveridge, Roy A Common Stock, par value $0.0001
Apr 11, 2022 Sell 2 741 Kutok Jeffery Common Stock, par value $0.0001
Apr 01, 2022 Buy 800 000 Korn Jerald Stock Option (Right to Buy)
Apr 01, 2022 Buy 800 000 Korn Jerald Stock Option (Right to Buy)
Mar 31, 2022 Buy 11 413 Beveridge, Roy A Common Stock, par value $0.0001
Mar 31, 2022 Buy 20 653 Mott David M Common Stock, par value $0.0001
Mar 31, 2022 Buy 13 043 Conroy Kevin T Common Stock, par value $0.0001
Mar 21, 2022 Buy 0 Korn Jerald
Mar 17, 2022 Buy 800 000 Bogle Grant C. Stock Option (Right to Buy)
Mar 17, 2022 Buy 800 000 Bogle Grant C. Stock Option (Right to Buy)
Mar 17, 2022 Buy 300 000 Beaulieu Joseph Stock Option (Right to Buy)
Mar 17, 2022 Buy 300 000 Beaulieu Joseph Stock Option (Right to Buy)
Mar 17, 2022 Buy 380 000 Kutok Jeffery Stock Option (Right to Buy)
Mar 17, 2022 Buy 380 000 Kutok Jeffery Stock Option (Right to Buy)
Mar 17, 2022 Buy 500 000 Agarwal Shefali Stock Option (Right to Buy)
Mar 17, 2022 Buy 500 000 Agarwal Shefali Stock Option (Right to Buy)
Feb 28, 2022 Buy 2 331 Beaulieu Joseph Common Stock
Feb 28, 2022 Buy 2 331 Agarwal Shefali Common Stock
Feb 07, 2022 Sell 222 Beaulieu Joseph Common Stock, par value $0.0001
Feb 07, 2022 Sell 1 058 Agarwal Shefali Common Stock, par value $0.0001
Feb 02, 2022 Sell 2 639 Agarwal Shefali Common Stock, par value $0.0001
Feb 02, 2022 Buy 417 500 Bogle Grant C. Stock Option (Right to Buy)
Feb 02, 2022 Buy 87 500 Bogle Grant C. Common Stock, par value $0.0001
Feb 02, 2022 Sell 2 556 Kutok Jeffery Common Stock, par value $0.0001
Feb 02, 2022 Sell 687 Beaulieu Joseph Common Stock, par value $0.0001
Jan 31, 2022 Buy 0 Royalty Pharma Investments 2019 Icav Common Stock
Jan 31, 2022 Buy 22 666 667 Legorreta Pablo G. Common Stock
Jan 26, 2022 Sell 2 922 Agarwal Shefali Common Stock, par value $0.0001
Dec 31, 2021 Buy 9 500 Mott David M Common Stock, par value $0.0001
Dec 31, 2021 Buy 6 000 Conroy Kevin T Common Stock, par value $0.0001
Dec 06, 2021 Sell 1 780 Agarwal Shefali Common Stock, par value $0.0001
Nov 16, 2021 Buy 83 298 Beveridge, Roy A Stock Option (Right to Buy)
Nov 16, 2021 Buy 16 702 Beveridge, Roy A Common Stock, par value $0.0001
INSIDER POWER
-14.975
Last 100 transactions
Buy: 31 679 726 | Sell: 42 571 145 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -14.975.

In total, the insiders bought 31 679 726 and sold 42 571 145 EPZM shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Epizyme

Epizyme Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in pa... EPZM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT